Efficacy of Kinesiotaping During Rehabilitation Following Total Knee Replacement Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Kinesiotaping (KT): Kinesiotaping will be applied using muscle, lymphatic, and ligament taping techniques to promote healing, reduce swelling, and improve muscle function following total knee replacement surgery.
Standard Rehabilitation: Patients will receive standard postoperative rehabilitation, including physiotherapy, gait training, and medical exercises, without the application of Kinesiotaping.
Study summary
The aim of this study was to examine the efficacy of Kinesiotaping (KT) within postoperative rehabilitation after Total Knee Replacement (TKR) surgery by determining whether KT enhances early postoperative outcomes, in terms of reduction of swelling, pain relief and improvement in the function of the knee joint, compared to conventional rehabilitation without the use of KT.
Eligibility
Primary outcome measure(s)
- Pain Level Using the Numeric Rating Scale (NRS) — From postoperative day 10 to postoperative day 25.
Pain Level Using the Numeric Rating Scale (NRS): Pain intensity will be assessed using the Numeric Rating Scale, ranging from 0 (no pain) to 10 (worst possible pain). Unit of Measure: NRS score (0-10), where higher scores indicate worse pain. - Knee Circumference (Swelling) — From postoperative day 10 to postoperative day 25.
Knee Circumference (Swelling): The circumference of the operated knee will be measured using a standard tape measure at a consistent anatomical location. Unit of Measure: Centimeters. - Passive Range of Motion (PROM) — From postoperative day 10 to postoperative day 25.
Passive Range of Motion (PROM): Knee joint mobility (flexion and extension) will be measured using a goniometer. Unit of Measure: Degrees.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| SRH Health Center Bad Herrenalb | Bad Herrenalb | Bad Herrenalb |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06831682 on ClinicalTrials.gov ↗ ← All trials in Germany